SCHEMBL13875979

SCHEMBL13875979

Cc1cccc2c1N1C(=CN(c3ccccc3)C1C)C2

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ AVPR1A P37288 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ AADAT Q8N5Z0 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13875971 0.80 HTR2C (0.35) HTR2AHTR2CHTR2BAADATSLC6A2
SCHEMBL13875985 0.73 HPGD (0.36) HTR2AHTR2CHTR2BAVPR1ANPC1
SCHEMBL12083515 0.70 GAA (0.32) —
SCHEMBL24547836 0.67 ALDH1A1 (0.34) HTR2AHTR2CHTR2BNPC1MAPT
SCHEMBL16709143 0.67 ALOX12 (0.40) HTR2AHTR2CHTR2BAADATSLC6A2
SCHEMBL13875992 0.67 ALDH1A1 (0.38) HTR2AHTR2CHTR2BMAPTRAB9A
SCHEMBL13875987 0.67 ALDH1A1 (0.38) HTR2AHTR2CHTR2BMAPTAADAT
SCHEMBL6416753 0.66 HPGD (0.40) HTR2AHTR2CHTR2BAVPR1ANPC1
SCHEMBL13875974 0.65 ALDH1A1 (0.39) HTR2AHTR2CHTR2BRAB9AAADAT
SCHEMBL24418855 0.62 ALDH1A1 (0.36) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692131-B2 Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes UDC IRELAND LIMITED (IE) 2023-07-04 — — US disclosed
US-8383828-B2 Transition metal complexes comprising one noncarbene ligand and one or two carbene ligands and their use in OLEDs BASF AKTIENGESELLSCHAFT (DE) 2013-02-26 — — US disclosed
US-20090096367-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2009-04-16 — — US disclosed
US-20090054657-A1 Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds BASF SE (DE) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096367-A1 HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) OCIAD2, OCIAD1, ICOSLG HTR2A 1921/4885HTR2C 1279/4885HTR2B 1293/4885
US-20090054657-A1 Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds OCIAD1, OCIAD2, ICOSLG HTR2A 1944/4885HTR2C 1278/4885HTR2B 1546/4885
US-11692131-B2 Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes CLTB, CLTC, CYBA HTR2A 1956/4885HTR2C 1562/4885HTR2B 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback